Drdgold annual return on equity
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Drdgold Return on Equity (ROE) Growth & History (DRD)
Drdgold's return on equity was 39.35% for fiscal 2026.
View full Drdgold company overviewDrdgold annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2026 | 2026-06-30 | 39.35% | +10.91 pp |
| 2025 | 2025-06-30 | 28.44% | +8.25 pp |
| 2024 | 2024-06-30 | 20.19% | −1.69 pp |
| 2023 | 2023-06-30 | 21.88% | −0.03 pp |
| 2022 | 2022-06-30 | 21.91% | −10.60 pp |
| 2021 | 2021-06-30 | 32.50% | +13.63 pp |
| 2020 | 2020-06-30 | 18.87% | +14.91 pp |
| 2019 | 2019-06-30 | 3.97% | +3.46 pp |
| 2018 | 2018-06-30 | 0.51% | −0.53 pp |
| 2017 | 2017-06-30 | 1.04% | — |
Drdgold return on equity trends
Over the last five fiscal years, Drdgold's return on equity increased from 32.50% to 39.35%, a change of +6.85 percentage points.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Drdgold source filings ↗